{
  "docId": "019de075-7c2e-7510-9012-23bac78506e5",
  "docSlug": "6afb08ad9ecba2144545352067526476",
  "documentTitle": "Bluejay | Investor Presentation Deck | 20 slides",
  "authorId": "bluejay",
  "authorName": "Bluejay Diagnostics",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-08-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 18,
  "pageCount": 20,
  "prevPage": 17,
  "nextPage": 19,
  "slideType": "appendix_data",
  "function": "analyze_data",
  "density": "dense",
  "nDataPoints": 7,
  "notes": "Includes both internal cash metrics and external NASDAQ market data.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-7c2e-7510-9012-23bac78506e5/18",
  "deckHref": "/decks/019de075-7c2e-7510-9012-23bac78506e5",
  "deckJsonHref": "/decks/019de075-7c2e-7510-9012-23bac78506e5.json",
  "deckAnchorHref": "/decks/019de075-7c2e-7510-9012-23bac78506e5#slide-18",
  "components": [
    {
      "bbox": {
        "h": 0.015,
        "w": 0.485,
        "x": 0.135,
        "y": 0.95
      },
      "kind": "disclaimer",
      "text": "The Symphony™ System and Symphony™ Cartridge have not been cleared or approved by the U.S. FDA",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f37c68e9-1369-48dd-9edc-2ae6ca287330",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.845,
        "w": 0.375,
        "x": 0.585,
        "y": 0.12
      },
      "kind": "image",
      "text": null,
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "05e539c7-2490-456c-831e-8fdabfe34bfc",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.525,
        "x": 0.038,
        "y": 0.545
      },
      "kind": "table",
      "text": "BJDX (NASDAQ) (August 22, 2023) Market Cap $7.6M Average Daily Trading Volume (30 day) 620K shares Shares Outstanding 1.0M Closing Price $7.11",
      "attrs": null,
      "subkind": "kpi",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "156eb21d-5313-4c28-b83a-f77e0ef6f47e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.185,
        "w": 0.525,
        "x": 0.038,
        "y": 0.218
      },
      "kind": "table",
      "text": "Financial Info (June 30, 2023) Cash* $5.1 M Est. Cash Runway < 12 months Clean Balance Sheet No outstanding warrants or debt",
      "attrs": null,
      "subkind": "kpi",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8448395c-1777-45fa-9f16-4f2a1d15e633",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.035,
        "w": 0.245,
        "x": 0.038,
        "y": 0.083
      },
      "kind": "title",
      "text": "Financial Highlights",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "55dd37eb-188d-447c-bde9-ffe3cea347d9",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Executive summary",
      "slug": "executive-summary",
      "agent": null,
      "layer": "slide",
      "matchId": "80e51bd1-973b-4e5e-99a9-ea91c16d61f5",
      "evidence": "table/kpi: BJDX (NASDAQ) (August 22, 2023) Market Cap $7.6M Average Daily Trading Volume (30 day) 620K shares Shares Outstanding 1.0M Closing Price $7.11",
      "confidence": 0.8
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [
    {
      "to": 20,
      "from": 4,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "c2e62651-f3f1-4333-88f5-3a258ba00fce",
      "evidence": "The deck implicitly discusses the cost of inaction by emphasizing the life-threatening nature of sepsis and the benefits of rapid diagnosis.",
      "position": 0,
      "objective": "Highlight the cost of not acting quickly in sepsis diagnosis and treatment.",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}